Unmasking MS: More Common Than You Think, and Why We Fight So Hard
DEC 03, 2025MS is not rare. It’s estimated that nearly 1 million people in the United States and 2.8 million worldwide live with MS.
Read More
Doctors who treat strokes use that mantra because every minute – even second -- the brain is deprived of blood damages the brain. In fact, for every minute a large vessel ischemic stroke isn’t treated, a patient can lose 1.9 million neurons, 13.8 billion synapses and 7 miles of fibers, on average. The damage can be devastating. Stroke is a leading cause of disability and the No. 5 cause of death in the United States.
That’s why stroke experts stress the importance of recognizing signs of stroke and taking quick action to receive treatment. Time is also the first question asked when a stroke patient arrives in an emergency department. Doctors count down between the time the patient was last seen well and arrival in an emergency department to determine treatment:
Up to 4.5 hours tPA (clot-busting medication)
6 hours tPA or thrombectomy (surgical removal of clot)
After 6 hours Aspirin and bed rest (medical management)
In 2017, a large multi-center trial ended up changing treatment recommendations for patients arriving between 6 and 24 hours after the time last seen well. Called the DAWN trial, it compared the benefit of treatment with thrombectomy versus medical management between 6 and 24 hours.
The trial took place in 20 countries and at 40 to 50 sites in the United States, including CHI Health. The plan was to enroll 500 patients. In January 2017, after more than 200 patients had been enrolled, the trial was abruptly stopped. And for good reason.
It was discovered that thrombectomies were working undeniably well. There was such a powerful cause-to-effect that it was determined medical management was simply not the preferred course of treatment for this group of patients. So the trial ended after 206 enrollees, which is far short of the preset safety target of 250. Such overwhelming results are relatively rare. The DAWN trial may have profound implications for treatment of stroke as it will allow many more patients be treated with thrombectomy. Read full information about the DAWN Trial.
See more about how a thrombectomy works. Questions? Contact the CHI Health Neurological Institute.
MS is not rare. It’s estimated that nearly 1 million people in the United States and 2.8 million worldwide live with MS.
Read More
While we can't always pinpoint an exact cause for every aneurysm, we've identified several key risk factors that can increase the likelihood of developing one, and more importantly, the risk of it rupturing.
Read More
Alzheimer's is a progressive brain disease that slowly destroys memory and thinking skills, and eventually, the ability to carry out the simplest tasks.
Read MoreWhen you need local health information from a trusted source, turn to the CHI Health Better You eNewsletter.